Mount Sinai School of Medicine - Medicine - Infectious Diseases
New York, New York, United States
Infectious disease physician in New York City, New York
5 E 98th St #11, New York, NY 10029
About Mount Sinai School of Medicine - Medicine - Infectious Diseases
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Institute of Allergy and Infectious Diseases (NIAID)
4
Glaxo Wellcome
1
Triangle Pharmaceuticals
1
Clinical Trials at Mount Sinai School of Medicine - Medicine - Infectious Diseases
During the past decade, Mount Sinai School of Medicine - Medicine - Infectious Diseases conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients
2000-05-01
Completed
100
A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
2000-08-01
Unknown status
CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL")
2012-10-29
2018-06-22
Completed
205
ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19
2020-10-23
2021-09-13
Completed
214
ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19
2020-10-19
2022-04-22
Completed
473
ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19
2021-07-21
2022-04-23
Completed
176
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Mount Sinai School of Medicine - Medicine - Infectious Diseases
According to Clinical.Site data, the most researched conditions in "Mount Sinai School of Medicine - Medicine - Infectious Diseases" are
"COVID-19" (3 trials), "HIV Infections" (2 trials), "Cytomegalovirus Infection" (1 trials) and "Lipodystrophy" (1 trials). Many other conditions were trialed in "Mount Sinai School of Medicine - Medicine - Infectious Diseases" in a lesser frequency.
Clinical Trials Intervention Types at Mount Sinai School of Medicine - Medicine - Infectious Diseases
Most popular intervention types in "Mount Sinai School of Medicine - Medicine - Infectious Diseases" are "Drug" (6 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Remdesivir" (3 trials), "Abacavir sulfate" (1 trials), "Danicopan" (1 trials) and "Didanosine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mount Sinai School of Medicine - Medicine - Infectious Diseases
The vast majority of trials in "Mount Sinai School of Medicine - Medicine - Infectious Diseases" are
6 trials for "All" genders.
Clinical Trials Status at Mount Sinai School of Medicine - Medicine - Infectious Diseases
Currently, there are NaN active trials in "Mount Sinai School of Medicine - Medicine - Infectious Diseases".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Mount Sinai School of Medicine - Medicine - Infectious Diseases,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Mount Sinai School of Medicine - Medicine - Infectious Diseases, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".